Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Jun 9, 2009


Greg Lucier, chairman and CEO of Life Technologies, will join the board of directors of CareFusion, the public company to emerge from the planned spinoff of Cardinal Health's clinical and medical products businesses.

Joe DeRisi has received the 2009 American Society for Microbiology Eli Lilly and Company Research Award. He is a professor in the department of biochemistry and biophysics at the University of California, San Francisco, School of Medicine and a Howard Hughes Medical Investigator. He is honored for his work in advancing the basic technology and informatics for DNA microarrays and using these tools to investigate basic biological regulatory mechanisms. Currently, he works on the application of advanced genomic technologies to the study of human infectious diseases. DeRisi holds a PhD from Stanford University.

Peter Barrett, Robert Higgins, and Theo Melas-Kyriazi were elected at Helicos BioSciences' annual stockholder meeting last week to continue as company directors until the 2012 annual meeting of stockholders, or until their successors are elected and qualified.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.